603811.SHG Zhejiang Cheng Yi Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
6.77 CNY
Close of Nov 5, 2026
6.40 9.16
Market cap
CNY 3.10B
P/E
16.5x
P/B
2.08x
ROE
12.2%
Dividend yield
2.69%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603811.SHG undervalued?

Graham number
Price6.77
Graham value5.48
Premium23.4%

603811.SHG trades 23.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Cheng Yi Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Cheng Yi Pharmaceutical Co Ltd yet.

Zhejiang Cheng Yi Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; …

Full company profile